Literature DB >> 18695138

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

Linda Morris Brown1, Susan S Devesa, Wong-Ho Chow.   

Abstract

Rapid increases in the incidence of adenocarcinoma of the esophagus have been reported among white men. We further explored the temporal patterns of this disease among white individuals by sex, stage, and age by use of data from the Surveillance, Epidemiology, and End Results program. We identified 22,759 patients from January 1, 1975, through December 31, 2004, with esophageal cancer, of whom 9526 were diagnosed with adenocarcinoma of the esophagus. Among white men, increases in the incidence of esophageal cancer were largely attributed to a 463% increase in the incidence of adenocarcinoma over this time period, from 1.01 per 100,000 person-years (95% confidence interval [CI] = 0.90 to 1.13) in 1975-1979 to 5.69 per 100,000 person-years (95% CI = 5.47 to 5.91) in 2000-2004. A similar rapid increase was also apparent among white women, among whom the adenocarcinoma rate increased 335%, from 0.17 (95% CI = 0.13 to 0.21) to 0.74 per 100,000 person-years (95% CI = 0.67 to 0.81), over the same time period. Adenocarcinoma rates rose among white men and women in all stage and age groups, indicating that these increases are real and not an artifact of surveillance.

Entities:  

Mesh:

Year:  2008        PMID: 18695138      PMCID: PMC2518165          DOI: 10.1093/jnci/djn211

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

Review 1.  Trends and patterns of prostate cancer: what do they suggest?

Authors:  A W Hsing; S S Devesa
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

Review 2.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

3.  Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type.

Authors:  Ahmedin Jemal; William D Travis; Robert E Tarone; Lois Travis; Susan S Devesa
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

4.  Graphical presentation of trends in rates.

Authors:  S S Devesa; J Donaldson; T Fears
Journal:  Am J Epidemiol       Date:  1995-02-15       Impact factor: 4.897

5.  Continuing climb in rates of esophageal adenocarcinoma: an update.

Authors:  W J Blot; S S Devesa; J F Fraumeni
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

6.  Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma.

Authors:  Catherine de Martel; Augusto E Llosa; Sara M Farr; Gary D Friedman; Joseph H Vogelman; Norman Orentreich; Douglas A Corley; Julie Parsonnet
Journal:  J Infect Dis       Date:  2005-01-20       Impact factor: 5.226

Review 7.  Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

8.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

9.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

Authors:  W J Blot; S S Devesa; R W Kneller; J F Fraumeni
Journal:  JAMA       Date:  1991-03-13       Impact factor: 56.272

10.  Declining lung cancer rates among young men and women in the United States: a cohort analysis.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1989-10-18       Impact factor: 13.506

View more
  287 in total

Review 1.  Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.

Authors:  Shelby D Melton; Robert M Genta; Rhonda F Souza
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

2.  Incidence of brain metastasis in patients with esophageal carcinoma.

Authors:  Ron S Smith; Robert C Miller
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

3.  Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.

Authors:  Michael A O'Rorke; Marie M Cantwell; Christian C Abnet; And John D Brockman; Liam J Murray
Journal:  Int J Cancer       Date:  2012-03-06       Impact factor: 7.396

4.  Esophageal squamous cell carcinoma - precursor lesions and early diagnosis.

Authors:  Antonio Barros Lopes; Renato Borges Fagundes
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

5.  Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus.

Authors:  Ling Yang; Li-Shu Wang; Xiaoxin Luke Chen; Zoran Gatalica; Suimin Qiu; Zhihua Liu; Gary Stoner; Hongwei Zhang; Heidi Weiss; Jingwu Xie
Journal:  Int J Biochem Mol Biol       Date:  2012-02-10

6.  Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies.

Authors:  Christian C Abnet; Zhaoming Wang; Xin Song; Nan Hu; Fu-You Zhou; Neal D Freedman; Xue-Min Li; Kai Yu; Xiao-Ou Shu; Jian-Min Yuan; Wei Zheng; Sanford M Dawsey; Linda M Liao; Maxwell P Lee; Ti Ding; You-Lin Qiao; Yu-Tang Gao; Woon-Puay Koh; Yong-Bing Xiang; Ze-Zhong Tang; Jin-Hu Fan; Charles C Chung; Chaoyu Wang; William Wheeler; Meredith Yeager; Jeff Yuenger; Amy Hutchinson; Kevin B Jacobs; Carol A Giffen; Laurie Burdett; Joseph F Fraumeni; Margaret A Tucker; Wong-Ho Chow; Xue-Ke Zhao; Jiang-Man Li; Ai-Li Li; Liang-Dan Sun; Wu Wei; Ji-Lin Li; Peng Zhang; Hong-Lei Li; Wen-Yan Cui; Wei-Peng Wang; Zhi-Cai Liu; Xia Yang; Wen-Jing Fu; Ji-Li Cui; Hong-Li Lin; Wen-Liang Zhu; Min Liu; Xi Chen; Jie Chen; Li Guo; Jing-Jing Han; Sheng-Li Zhou; Jia Huang; Yue Wu; Chao Yuan; Jing Huang; Ai-Fang Ji; Jian-Wei Kul; Zhong-Min Fan; Jian-Po Wang; Dong-Yun Zhang; Lian-Qun Zhang; Wei Zhang; Yuan-Fang Chen; Jing-Li Ren; Xiu-Min Li; Jin-Cheng Dong; Guo-Lan Xing; Zhi-Gang Guo; Jian-Xue Yang; Yi-Ming Mao; Yuan Yuan; Er-Tao Guo; Wei Zhang; Zhi-Chao Hou; Jing Liu; Yan Li; Sa Tang; Jia Chang; Xiu-Qin Peng; Min Han; Wan-Li Yin; Ya-Li Liu; Yan-Long Hu; Yu Liu; Liu-Qin Yang; Fu-Guo Zhu; Xiu-Feng Yang; Xiao-Shan Feng; Zhou Wang; Yin Li; She-Gan Gao; Hai-Lin Liu; Ling Yuan; Yan Jin; Yan-Rui Zhang; Ilyar Sheyhidin; Feng Li; Bao-Ping Chen; Shu-Wei Ren; Bin Liu; Dan Li; Gao-Fu Zhang; Wen-Bin Yue; Chang-Wei Feng; Qirenwang Qige; Jian-Ting Zhao; Wen-Jun Yang; Guang-Yan Lei; Long-Qi Chen; En-Min Li; Li-Yan Xu; Zhi-Yong Wu; Zhi-Qin Bao; Ji-Li Chen; Xian-Chang Li; Xiang Zhuang; Ying-Fa Zhou; Xian-Bo Zuo; Zi-Ming Dong; Lu-Wen Wang; Xue-Pin Fan; Jin Wang; Qi Zhou; Guo-Shun Ma; Qin-Xian Zhang; Hai Liu; Xin-Ying Jian; Sin-Yong Lian; Jin-Sheng Wang; Fu-Bao Chang; Chang-Dong Lu; Jian-Jun Miao; Zhi-Guo Chen; Ran Wang; Ming Guo; Zeng-Lin Fan; Ping Tao; Tai-Jing Liu; Jin-Chang Wei; Qing-Peng Kong; Lei Fan; Xian-Zeng Wang; Fu-Sheng Gao; Tian-Yun Wang; Dong Xie; Li Wang; Shu-Qing Chen; Wan-Cai Yang; Jun-Yan Hong; Liang Wang; Song-Liang Qiu; Alisa M Goldstein; Zhi-Qing Yuan; Stephen J Chanock; Xue-Jun Zhang; Philip R Taylor; Li-Dong Wang
Journal:  Hum Mol Genet       Date:  2012-02-08       Impact factor: 6.150

Review 7.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

8.  Transcriptome profiling of the cancer and normal tissues from gastric cancer patients by deep sequencing.

Authors:  Fei-Gong Zhang; Zhi-Ying He; Qiang Wang
Journal:  Tumour Biol       Date:  2014-04-30

9.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

10.  Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.

Authors:  Allyson J Ocean; Paul Christos; Joseph A Sparano; Manish A Shah; Rhonda K Yantiss; Jonathan Cheng; Juan Lin; Michael Papetti; Dan Matulich; Felice Schnoll-Sussman; Christen Besanceney-Webler; Jenny Xiang; Maureen Ward; Kaili Temple Dilts; Roger Keresztes; Shannon Holloway; Eric X Chen; John J Wright; Maureen E Lane
Journal:  Invest New Drugs       Date:  2014-02-15       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.